CXCL10 and metabolic dysfunction-associated steatohepatitis: A paper by Zhang et al. [91], described elevated serum CXCL10 in patients with fatty liver and nonalcoholic steatohepatitis, noting histological correlation between CXCL10 levels and liver disease.